CA2642921A1 - 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors - Google Patents

4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors Download PDF

Info

Publication number
CA2642921A1
CA2642921A1 CA002642921A CA2642921A CA2642921A1 CA 2642921 A1 CA2642921 A1 CA 2642921A1 CA 002642921 A CA002642921 A CA 002642921A CA 2642921 A CA2642921 A CA 2642921A CA 2642921 A1 CA2642921 A1 CA 2642921A1
Authority
CA
Canada
Prior art keywords
thiazole
carboxylic acid
phenyl
benzoimidazol
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002642921A
Other languages
English (en)
French (fr)
Inventor
John Frederick Boylan
Jianping Cai
Nader Fotouhi
Paul Gillespie
Robert Alan Goodnow Jr.
Kang Le
Christophe Michoud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2642921A1 publication Critical patent/CA2642921A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CA002642921A 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors Abandoned CA2642921A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27
US60/776,964 2006-02-27
PCT/EP2007/051541 WO2007096315A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Publications (1)

Publication Number Publication Date
CA2642921A1 true CA2642921A1 (en) 2007-08-30

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002642921A Abandoned CA2642921A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Country Status (19)

Country Link
US (1) US7504513B2 (OSRAM)
EP (1) EP1991543A1 (OSRAM)
JP (1) JP2009528284A (OSRAM)
KR (1) KR101060539B1 (OSRAM)
CN (1) CN101415704A (OSRAM)
AR (1) AR059621A1 (OSRAM)
AU (1) AU2007217575A1 (OSRAM)
BR (1) BRPI0710473A2 (OSRAM)
CA (1) CA2642921A1 (OSRAM)
CR (1) CR10206A (OSRAM)
EC (1) ECSP088700A (OSRAM)
IL (1) IL193481A0 (OSRAM)
MA (1) MA30260B1 (OSRAM)
MX (1) MX2008010884A (OSRAM)
NO (1) NO20083708L (OSRAM)
RU (1) RU2008138163A (OSRAM)
TW (1) TW200745097A (OSRAM)
WO (1) WO2007096315A1 (OSRAM)
ZA (1) ZA200807074B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8412867B2 (en) * 2007-06-08 2013-04-02 Nec Corporation Semiconductor integrated circuit and filter and informational delivery method using same
WO2009094224A1 (en) 2008-01-25 2009-07-30 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
CN102056607B (zh) * 2008-04-17 2014-07-30 约翰·霍普金斯大学 On01910.na促进在抗药性肿瘤中化学治疗剂的活性
ES2388570T3 (es) * 2008-09-10 2012-10-16 Datalase Ltd Medio de almacenamiento de datos
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
CA2745596A1 (en) * 2008-12-18 2010-10-28 F. Hoffmann-La Roche Ag Thiazolyl-benzimidazoles
US9139589B2 (en) 2009-01-30 2015-09-22 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EP2603216A4 (en) 2010-08-11 2013-12-18 Millennium Pharm Inc HETEROARYLE AND USES THEREOF
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
UY33671A (es) 2010-10-13 2012-04-30 Millenium Pharmaceuticals Inc Heteroarilos y sus usos

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) * 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) * 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) * 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
DE60143041D1 (de) 2000-08-10 2010-10-21 Pfizer Italia Srl Bizyklische pyrazole wirksam als kinase inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
AU2003206946A1 (en) 2002-02-22 2003-09-09 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
WO2003072554A1 (fr) * 2002-02-28 2003-09-04 Takeda Chemical Industries, Ltd. Composes d'azole
ES2373945T3 (es) 2002-02-28 2012-02-10 Temple University - Of The Commonwealth System Of Higher Education Bencilsulfonas de (e)-2,6-dialcoxiestirilo amino sustituido sustituidas en 4 para tratar trastornos proliferativos.
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
KR20040106451A (ko) 2002-05-03 2004-12-17 쉐링 악티엔게젤샤프트 폴로-유사 키나제 억제제로서의 티아졸리디논 및 그의 용도
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
MXPA05001544A (es) 2002-08-08 2005-04-19 Smithkline Beecham Corp Compuestos de tiofeno.
WO2004043936A1 (ja) 2002-11-14 2004-05-27 Kyowa Hakko Kogyo Co., Ltd. Plk阻害剤
WO2004046317A2 (en) 2002-11-14 2004-06-03 Massachusetts Institue Of Technology Products and processes for modulating peptide-peptide binding domain interactions
JP3837670B2 (ja) 2002-12-12 2006-10-25 富士通株式会社 データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
EP1597251B1 (en) 2003-02-20 2009-06-10 SmithKline Beecham Corporation Pyrimidine compounds
JP2006522127A (ja) 2003-04-01 2006-09-28 スミスクライン ビーチャム コーポレーション イミダゾトリアジン化合物
KR20070092333A (ko) 2003-06-24 2007-09-12 화이자 프로덕츠 인크. 1-[(벤조이미다졸-1-일)퀴놀린-8-일]피페리딘-4-일아민유도체의 제조 방법
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
JP5164380B2 (ja) 2003-10-21 2013-03-21 サイクラセル リミテッド ピリミジン−4−イル−3,4−チオン化合物及び治療におけるその使用
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
JP2007519720A (ja) 2004-01-28 2007-07-19 スミスクライン ビーチャム コーポレーション チアゾール化合物

Also Published As

Publication number Publication date
ZA200807074B (en) 2009-10-28
AU2007217575A1 (en) 2007-08-30
MA30260B1 (fr) 2009-03-02
MX2008010884A (es) 2008-09-03
NO20083708L (no) 2008-09-23
IL193481A0 (en) 2009-05-04
CN101415704A (zh) 2009-04-22
JP2009528284A (ja) 2009-08-06
TW200745097A (en) 2007-12-16
KR20080090550A (ko) 2008-10-08
ECSP088700A (es) 2008-09-29
KR101060539B1 (ko) 2011-08-30
AR059621A1 (es) 2008-04-16
US7504513B2 (en) 2009-03-17
BRPI0710473A2 (pt) 2011-08-16
US20070203210A1 (en) 2007-08-30
RU2008138163A (ru) 2010-04-10
EP1991543A1 (en) 2008-11-19
WO2007096315A1 (en) 2007-08-30
CR10206A (es) 2008-09-22

Similar Documents

Publication Publication Date Title
US7504513B2 (en) Thiazolyl-benzimidazoles
JP4805916B2 (ja) 化合物、組成物、および方法
CA2778115C (en) Imidazole derivatives as ido inhibitors
CA2072541C (en) Heterocyclic compounds, their production and use
KR101081293B1 (ko) 11 베타-에이치에스디1 억제제로서 티아졸
CA2711603A1 (en) Activators of executioner procaspases 3, 6 and 7
US9073881B2 (en) Benzoic acid derivatives
CN104003940B (zh) 2,4‑二氟‑5‑(酞嗪酮‑1‑甲基)‑苯甲酰哌嗪类化合物及其用途
CN101835766B (zh) 作为腺苷a1受体拮抗体的化合物
US20100069453A1 (en) Certain Chemical Entities, Compositions, and Methods
CA2985542A1 (en) Triazole agonists of the apj receptor
JP2002537298A (ja) ピリジン化合物およびその医薬用途
US8163739B2 (en) 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
AU2008253684A1 (en) Pyrimidinones as Casein kinase II (CK2) modulators
WO2009129211A1 (en) Inhibitors of phosphatidylinositol 3-kinase
WO2012131501A1 (en) Substituted benzimidazole compounds as cot kinase inhibitors
US7714010B2 (en) Pyrrolobenzimidazolones and their use as anti-proliferative agents
WO2013176293A1 (en) Novel bicyclic thiazole compounds
CN114621194B (zh) 一种4-亚甲基-n-羟基苯甲酰胺类化合物及其应用
CN116655538A (zh) 一种淋巴瘤治疗药物中间体的制备方法
AU2020264679B2 (en) Selective ligands of human constitutive androstane receptor
JP2009514865A (ja) 有糸分裂キネシン阻害剤
HK1168106B (en) Imidazole derivatives as ido inhibitors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140219